Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25209 | Temozolomide | 85622-93-1 | ≧98.0% |  |
| Temozolomide is an alkylating agent. | ||||
| 186269 | TAK-071 | 1820812-16-5 | ≧98.0% |  |
| TAK-071 is a muscarinic M1 receptor positive allosteric modulator. | ||||
| 25137 | Tebapivat | 2283422-04-6 | 98% Min. |  |
| Tebapivat is a pyruvate kinase activator. | ||||
| 25121 | Triolex | 1001100-69-1 | 98% Min. |  |
| Triolex is an NF-kB inhibitor potentially for the treatment of rheumatoid arthritis, | ||||
| 25113 | Triheptanoin | 620-67-7 | 98% Min. |  |
| Triheptanoin is a fatty acid metabolic modulator potentially for treatment of fatty a | ||||
| 25088 | Tonabersat ( SB-220453 ) | 175013-84-0 | ≧98.0% |  |
| Tonabersat, also known as SB-220453, is gap-junction modulator for the prevention of | ||||
| 25072 | TG101209 analog 1 | 98% Min. |  | |
| TG101209 analog 1 (Compound 8h) is an inhibitor of BUB1B with an IC50 of 10.36 μ M. | ||||
| 25070 | TAK-653 | 1358751-06-0 | 98% Min. |  |
| TAK-653 is a novel AMPA receptor potentiator, strictly potentiating a glutamate-induc | ||||
| 25061 | TGN 073 | 877459-36-4 | 98% Min. |  |
| TGN 073 is a facilitator of aquaporin-4 (AQP4), an astroglial water channel. The rats | ||||
| 25049 | TAK-779 | 229005-80-5 | 98% Min. |  |
| TAK-779 is a C-C chemokine receptor type 5 (CCR5) receptor antagonist potentially for | ||||
| 24149 | TM5441sodium | 2319722-53-5 | 98% Min. |  |
| TM-5441, also known as EBP 883 and BMS-790052, is a potent plasminogen activator inhi | ||||
| 24147 | TRPM4-IN-2 | 667411-04-3 | 98% Min. |  |
| TRPM4-IN-2 (NBA) is a potent transient receptor potential melastatin 4 (TRPM4) inhibi | ||||
| 24141 | TCRS-417 | 2032123-28-5 | 98% Min. |  |
| TCRS-417 (T417) is a small molecule compound capable of docking to the interface betw | ||||
| 24102 | Talabostat | 149682-77-9 | 98% Min. |  |
| Talabostat, also known as PT-100 and BXCL701, is dipeptidyl peptidase inhibitor with | ||||
| 24099 | Tasurgratinib | 1622204-21-0 | 98% Min. |  |
| Tasurgratinib, also known as E-7090, is a fibroblast growth factor receptor inhibitor | ||||
| 24085 | tunlametinibum | 1801756-06-8 | 98% Min. |  |
| tunlametinibum is a tyrosine kinase inhibitor and antineoplastic | ||||
| 24071 | tambiciclib dimaleate | 2559759-04-3 | 98% Min. |  |
| 24069 | Tuvusertib | 1613200-51-3 | ≧98.0% |  |
| Tuvusertib, also known as M-1774 and ATR inhibitor 1, is a ATR inhibitor. M1774 selec | ||||
| 24062 | tert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate | 942271-61-6 | 98% Min. | -2-nitrobenzoate_942271-61-6.png) |
| 24061 | 5-(Trifluoromethyl)picolinonitrile | 95727-86-9 | 98% Min. | picolinonitrile_95727-86-9.png) |
| 20673 | Tomivosertib HCl | 1849590-02-8 | 98% Min. |  |
| Tomivosertib, also known as eFT508 is a MNK1/2 inhibitor. Tomivosertib binds to and i | ||||
| 20667 | TYA-018 | 2653254-31-8 | 98% Min. |  |
| TYA-018 is an orally active, potent and highly selective HDAC6 inhibitor. | ||||
| 24004 | T-1095 | 209746-59-8 | ≧96.0% |  |
| T-1095 is a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs). | ||||
| 24002 | Tert-butyl 6,11-dioxo-6,11-dihydro-5H-benzo[b]carbazole-2-carboxylate | 3024657-88-0 | ≧96.0% |  |
| Tert-butyl 6,11-dioxo-6,11-dihydro-5H-benzo[b]carbazole-2-carboxylate, CAS 3024657-88 | ||||
| 20660 | TT-012 | 1164471-33-3 | 98% Min. |  |
| TT-012 specifically binds to dynamic MITF and destroys the latter's dimer formati | ||||
| 20646 | TNG908 | 2760481-53-4 | ≧98.0% |  |
| TNG908 is a clinical stage MTA-cooperative PRMT5 inhibitor that is selectively active | ||||
| 20633 | Tersolisib ( STX-478 ) | 2883540-92-7 | ≧98.0% |  |
| Tersolisib ( STX-478 )is a second generation, mutant-selective, oral PI3Ka small mole | ||||
| 20598 | Tilpisertib Fosmecarbil | 2567459-64-5 | 98% Min. |  |
| Tilpisertib fosmecarbil is a potent serine/threonine kinase inhibitor. | ||||
| 20557 | TZ3O | 2218754-19-7 | 98% Min. |  |
| TZ3O (compound TZ30) is an anticholinergic agent with neuroprotective effects. | ||||
| 20553 | Tinengotinib ( TT-00420) | 2230490-29-4 | ≧98.0% |  |
| Tinengotinib ( TT-00420) is a novel multiple kinase inhibitor that strongly inhibited | ||||